Biotechnology · Healthcare
Board Member
2026-06-17–present
Board Member
CytomX Therapeutics, Inc. (CTMX)Equibles does not estimate personal net worth.
Get an email with a short summary when CytomX Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CTMX alertsElaine V. Jones Ph.D. is recorded as Board Member at CytomX Therapeutics, Inc. (CTMX) since June 17, 2026. CytomX Therapeutics, Inc. reported in an 8-K filed June 22, 2026 that Elaine V. Jones Ph.D. was appointed Class II director, effective June 17, 2026. CytomX Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CytomX Therapeutics, Inc. includes Sean McCarthy (CEO and Board Member), Chris Ogden (CFO and Chief Accounting Officer), Lloyd A. Rowland (General Counsel) and 7 others.
“The Company’s stockholders elected the Class II director nominees below to the Board to hold office until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or the earlier of their death, resignation or removal.”
2026-06-17–present
Biotechnology · Healthcare
Board Member
2026-06-17–present